Market Study on Statins: Continuously Rising Cholesterol-related Issues to Benefit Market Players

Sep 2022| PMR2012A| Persistence Market Research

Report Highlights

Statins Market: Report Scope

The latest market report by Persistence Market Research on the global statins market evaluates the opportunities and current market scenario, providing insights and updates about corresponding segments involved in the market for the forecast period of 2022-2032. The report provides detailed assessment of key market dynamics, and comprehensive information about the structure of the market. This study contains detailed insights into how the market is anticipated to grow during the forecast period of 2022-2032.

The primary objective of the report is to provide insights regarding opportunities in the market that are supporting the transformation of global businesses associated with Statins. It is very important to consider that, in an ever-wavering economy, we provide estimated (Y-o-Y) year-on-year growth rate in addition to compound annual growth rate (CAGR) for overall forecasts, to enable readers better understand the analysis and evaluation of the market, and to discover lucrative opportunities in this space.

This report also provides an estimate of market size and corresponding revenue forecasts carried out in terms of absolute $ opportunity. It also offers actionable insights based on the future trends in the market. Furthermore, new and emerging players in the global statins market can make use of the information presented in the study for effective business decisions, which will provide momentum to their businesses as well as the global market.

The study is relevant for manufacturers, suppliers, distributors, and investors in the statins market. All stakeholders, as well as industry experts, researchers, journalists, and business researchers can leverage the information and data represented in the report.

Key Market Segments

Persistence Market Research’s report on the global statins market offers information divided into four segments – drug class, therapeutic treatment, end user and region.

Drug Class

  • Astrovastatin
  • Fluvastatin
  • Lovastatin
  • Pravastatin
  • Simvastatin
  • Others

Therapeutic Treatment

  • Cardiovascular Disorders
  • Obesity
  • Inflammatory Disorders
  • Others

End User

  • Hospitals
  • Clinics

Region

  • North America
  • Latin America
  • Europe
  • South Asia and Pacific
  • East Asia
  • Middle East and Africa

Key Questions Answered in Study

  • Which region will hold the highest market share over the forecast period?
  • Which region is experiencing the highest growth (CAGR)?
  • Which factors are impacting the global statins industry?
  • What are the global trends impacting the market?
  • What strategies must emerge players adopt to capture opportunities in various regions in the market?
  • What is the structure of the global statins market?

Report Synopsis

Report Metrics Details
Base year considered 2021
Forecast period considered 2022-2032
Units considered $ Million
Segments covered Drug Class, Therapeutic Treatment, End User, Region
Industry covered Healthcare
Countries covered North America, Latin America, Europe, South Asia and Pacific, East Asia, Middle East and Africa
Companies studied
  • Pfizer Inc.
  • AstraZeneca plc
  • Novartis International AG
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Biocon
  • Aurobindo Pharma Ltd
  • Concord Biotech

Research Methodology

Persistence Market Research is committed to providing unbiased market research solutions to its clients. The company follows a robust methodology for the deduction of data included in this report. A unique research methodology is utilized to conduct extensive research on the global statins market, and reach conclusions about the future growth factors of the market. The research methodology comprises primary research methods coupled with secondary research methods, which ensures the accuracy and reliability of the conclusions in this report.

A demand-side approach is followed to estimate the sales of target products, followed by an in-depth supply-side assessment of value generated, key trends, and events over a predefined period.

This methodology is based on standard market structures, methods, and definitions that are based on inputs from local sources in over six regions - North America, Latin America, Europe, South Asia and Pacific, East Asia, and the Middle East & Africa, which Persistence Market Research considers for segmenting the global market. Statistics, characteristics, and variances are collected at a regional level, aggregated at the same level, and then synthesized at a worldwide level, to create global market measurements.

Our main sources of research include:

  • Primary Research
  • Secondary Research
  • Trade Research
  • Social Media Research
  • Table 1 : Global Statins Market Volume ('000 Units) & Value (US$ Mn) Forecast by Drug Class, 2017– 2032
  • Table 2 : Global Statins Market Volume ('000 Units) & Value (US$ Mn) Forecast by Therapeutic Treatment, 2017– 2032
  • Table 3 : Global Statins Market Volume ('000 Units) & Value(US$ Mn) Forecast by End User, 2017– 2032
  • Table 4 : Global Statins Market Volume ('000 Units) & Value (US$ Mn) Forecast by Region, 2017– 2032
  • Table 5 : North America Statins Market Volume ('000 Units) & Value (US$ Mn) Forecast by Country, 2017– 2032
  • Table 6 : North America Statins Market Volume ('000 Units) & Value (US$ Mn) Forecast by Drug Class, 2017– 2032
  • Table 7 : North America Statins Market Volume ('000 Units) & Value (US$ Mn) Forecast by Therapeutic Treatment, 2017– 2032
  • Table 8 : North America Statins Market Volume ('000 Units) & Value(US$ Mn) Forecast by End User, 2017– 2032
  • Table 9 : Latin America Statins Market Volume ('000 Units) & Value (US$ Mn) Forecast by Country, 2017– 2032
  • Table 10 : Latin America Statins Market Volume ('000 Units) & Value (US$ Mn) Forecast by Drug Class, 2017– 2032
  • Table 11 : Latin America Statins Market Volume ('000 Units) & Value (US$ Mn) Forecast by Therapeutic Treatment, 2017– 2032
  • Table 12 : Latin America Statins Market Volume ('000 Units) & Value(US$ Mn) Forecast by End User, 2017– 2032
  • Table 13 : Europe Statins Market Volume ('000 Units) Forecast by Country 2017– 2032
  • Table 14 : Europe Statins Market Value(US $ Mn) Forecast by Country, 2017– 2032
  • Table 15 : Europe Statins Market Volume ('000 Units) & Value (US$ Mn) Forecast by Drug Class, 2017– 2032
  • Table 16 : Europe Statins Market Volume ('000 Units) & Value (US$ Mn) Forecast by Therapeutic Treatment, 2017– 2032
  • Table 17 : Europe Statins Market Volume ('000 Units) & Value(US$ Mn) Forecast by End User, 2017– 2032
  • Table 18 : South Asia & Pacific Statins Market Volume ('000 Units) & Value(US$ Mn) Forecast by Country,2017– 2032
  • Table 19 : South Asia & Pacific Statins Market Volume ('000 Units) & Value (US$ Mn) Forecast by Drug Class, 2017– 2032
  • Table 20 : South Asia & Pacific Statins Market Volume ('000 Units) & Value (US$ Mn) Forecast by Therapeutic Treatment, 2017– 2032
  • Table 21 : South Asia & Pacific Statins Market Volume ('000 Units) & Value(US$ Mn) Forecast by End User, 2017– 2032
  • Table 22 : East Asia Statins Market Volume ('000 Units) & Value (US$ Mn) Forecast by Country, 2017– 2032
  • Table 23 : East Asia Statins Market Volume ('000 Units) & Value (US$ Mn) Forecast by Drug Class, 2017– 2032
  • Table 24 : East Asia Statins Market Volume ('000 Units) & Value (US$ Mn) Forecast by Therapeutic Treatment, 2017– 2032
  • Table 25 : East Asia Statins Market Volume ('000 Units) & Value(US$ Mn) Forecast by End User, 2017– 2032
  • Table 26 : Middle East & Africa Statins Market Volume ('000 Units) & Value(US$ Mn) Forecast by Country, 2017– 2032
  • Table 27 : Middle East & Africa Statins Market Volume ('000 Units) & Value (US$ Mn) Forecast by Drug Class, 2017– 2032
  • Table 28 : Middle East & Africa Statins Market Volume ('000 Units) & Value (US$ Mn) Forecast by Therapeutic Treatment, 2017– 2032
  • Table 29 : Middle East & Africa Statins Market Volume ('000 Units) & Value(US$ Mn) Forecast by End User, 2017– 2032
  • Figure 1 : Global Statins Market Historical Volume (‘000 Units), 2017 – 2021
  • Figure 2 : Global Statins Market Volume (‘000 Units) Forecast, 2022 – 2032
  • Figure 3 : Global Statins Market Size (2017-2021)
  • Figure 4 : Global Statins Absolute $ Opportunity Analysis (2017-2032)
  • Figure 5 : Global Statins Market Size (2022-2032)
  • Figure 6 : Global Statins Market BPS Analysis by Drug Class– 2022 & 2032
  • Figure 7 : Global Statins Market Y-o-Y Growth by Drug Class, 2021– 2032
  • Figure 8 : Global Statins Market Attractiveness Analysis by Drug Class, 2022– 2032
  • Figure 9 : Global Statins Market BPS Analysis by Therapeutic Treatment– 2022 & 2032
  • Figure 10 : Global Statins Market Y-o-Y Growth by Therapeutic Treatment, 2021– 2032
  • Figure 11 : Global Statins Market Attractiveness Analysis by Therapeutic Treatment, 2022– 2032
  • Figure 12 : Global Statins Market BPS Analysis by End User– 2022 & 2032
  • Figure 13 : Global Statins Market Y-o-Y Growth by End User, 2021– 2032
  • Figure 14 : Global Statins Market Attractiveness Analysis by End User, 2022– 2032
  • Figure 15 : Global Statins Market BPS Analysis by Region– 2022 & 2032
  • Figure 16 : Global Statins Market Y-o-Y Growth by Region, 2021– 2032
  • Figure 17 : Global Statins Market Attractiveness Analysis by Region, 2022– 2032
  • Figure 18 : North America Statins Market BPS Analysis by Country– 2022 & 2032
  • Figure 19 : North America Statins Market Y-o-Y Growth by Country, 2021– 2032
  • Figure 20 : North America Statins Market Attractiveness Analysis by Country, 2022– 2032
  • Figure 21 : North America Statins Market BPS Analysis by Drug Class– 2022 & 2032
  • Figure 22 : North America Statins Market Y-o-Y Growth by Drug Class, 2021– 2032
  • Figure 23 : North America Statins Market Attractiveness Analysis by Drug Class, 2022– 2032
  • Figure 24 : North America Statins Market BPS Analysis by Therapeutic Treatment– 2022 & 2032
  • Figure 25 : North America Statins Market Y-o-Y Growth by Therapeutic Treatment, 2021– 2032
  • Figure 26 : North America Statins Market Attractiveness Analysis by Therapeutic Treatment, 2022– 2032
  • Figure 27 : North America Statins Market BPS Analysis by End User– 2022 & 2032
  • Figure 28 : North America Statins Market Y-o-Y Growth by End User, 2021– 2032
  • Figure 29 : North America Statins Market Attractiveness Analysis by End User, 2022– 2032
  • Figure 30 : Latin America Statins Market BPS Analysis by Country– 2022 & 2032
  • Figure 31 : Latin America Statins Market Y-o-Y Growth by Country, 2021– 2032
  • Figure 32 : Latin America Statins Market Attractiveness Analysis by Country, 2022– 2032
  • Figure 33 : Latin America Statins Market BPS Analysis by Drug Class– 2022 & 2032
  • Figure 34 : Latin America Statins Market Y-o-Y Growth by Drug Class, 2021– 2032
  • Figure 35 : Latin America Statins Market Attractiveness Analysis by Drug Class, 2022– 2032
  • Figure 36 : Latin America Statins Market BPS Analysis by Therapeutic Treatment– 2022 & 2032
  • Figure 37 : Latin America Statins Market Y-o-Y Growth by Therapeutic Treatment, 2021– 2032
  • Figure 38 : Latin America Statins Market Attractiveness Analysis by Therapeutic Treatment, 2022– 2032
  • Figure 39 : Latin America Statins Market BPS Analysis by End User– 2022 & 2032
  • Figure 40 : Latin America Statins Market Y-o-Y Growth by End User, 2021– 2032
  • Figure 41 : Latin America Statins Market Attractiveness Analysis by End User, 2022– 2032
  • Figure 42 : Europe Statins Market BPS Analysis by Country– 2022 & 2032
  • Figure 43 : Europe Statins Market Y-o-Y Growth by Country, 2021– 2032
  • Figure 44 : Europe Statins Market Attractiveness Analysis by Country, 2022– 2032
  • Figure 45 : Europe Statins Market BPS Analysis by Drug Class– 2022 & 2032
  • Figure 46 : Europe Statins Market Y-o-Y Growth by Drug Class, 2021– 2032
  • Figure 47 : Europe Statins Market Attractiveness Analysis by Drug Class, 2022– 2032
  • Figure 48 : Europe Statins Market BPS Analysis by Therapeutic Treatment– 2022 & 2032
  • Figure 49 : Europe Statins Market Y-o-Y Growth by Therapeutic Treatment, 2021– 2032
  • Figure 50 : Europe Statins Market Attractiveness Analysis by Therapeutic Treatment, 2022– 2032
  • Figure 51 : Europe Statins Market BPS Analysis by End User– 2022 & 2032
  • Figure 52 : Europe Statins Market Y-o-Y Growth by End User, 2021– 2032
  • Figure 53 : Europe Statins Market Attractiveness Analysis by End User, 2022– 2032
  • Figure 54 : South Asia & Pacific Statins Market BPS Analysis by Country– 2022 & 2032
  • Figure 55 : South Asia & Pacific Statins Market Y-o-Y Growth by Country, 2021– 2032
  • Figure 56 : South Asia & Pacific Statins Market Attractiveness Analysis by Country, 2022– 2032
  • Figure 57 : South Asia & Pacific Statins Market BPS Analysis by Drug Class– 2022 & 2032
  • Figure 58 : South Asia & Pacific Statins Market Y-o-Y Growth by Drug Class, 2021– 2032
  • Figure 59 : South Asia & Pacific Statins Market Attractiveness Analysis by Drug Class, 2022– 2032
  • Figure 60 : South Asia & Pacific Statins Market BPS Analysis by Therapeutic Treatment– 2022 & 2032
  • Figure 61 : South Asia & Pacific Statins Market Y-o-Y Growth by Therapeutic Treatment, 2021– 2032
  • Figure 62 : South Asia & Pacific Statins Market Attractiveness Analysis by Therapeutic Treatment, 2022– 2032
  • Figure 63 : South Asia & Pacific Statins Market BPS Analysis by End User– 2022 & 2032
  • Figure 64 : South Asia & Pacific Statins Market Y-o-Y Growth by End User, 2021– 2032
  • Figure 65 : South Asia & Pacific Statins Market Attractiveness Analysis by End User, 2022– 2032
  • Figure 66 : East Asia Statins Market BPS Analysis by Country– 2022 & 2032
  • Figure 67 : East Asia Statins Market Y-o-Y Growth by Country, 2021– 2032
  • Figure 68 : East Asia Statins Market Attractiveness Analysis by Country, 2022– 2032
  • Figure 69 : East Asia Statins Market BPS Analysis by Drug Class– 2022 & 2032
  • Figure 70 : East Asia Statins Market Y-o-Y Growth by Drug Class, 2021– 2032
  • Figure 71 : East Asia Statins Market Attractiveness Analysis by Drug Class, 2022– 2032
  • Figure 72 : East Asia Statins Market BPS Analysis by Therapeutic Treatment– 2022 & 2032
  • Figure 73 : East Asia Statins Market Y-o-Y Growth by Therapeutic Treatment, 2021– 2032
  • Figure 74 : East Asia Statins Market Attractiveness Analysis by Therapeutic Treatment, 2022– 2032
  • Figure 75 : East Asia Statins Market BPS Analysis by End User– 2022 & 2032
  • Figure 76 : East Asia Statins Market Y-o-Y Growth by End User, 2021– 2032
  • Figure 77 : East Asia Statins Market Attractiveness Analysis by End User, 2022– 2032
  • Figure 78 : Middle East & Africa Statins Market BPS Analysis by Country– 2022 & 2032
  • Figure 79 : Middle East & Africa Statins Market Y-o-Y Growth by Country, 2021– 2032
  • Figure 80 : Middle East & Africa Statins Market Attractiveness Analysis by Country, 2022– 2032
  • Figure 81 : Middle East & Africa Statins Market BPS Analysis by Drug Class– 2022 & 2032
  • Figure 82 : Middle East & Africa Statins Market Y-o-Y Growth by Drug Class, 2021– 2032
  • Figure 83 : Middle East & Africa Statins Market Attractiveness Analysis by Drug Class, 2022– 2032
  • Figure 84 : Middle East & Africa Statins Market BPS Analysis by Therapeutic Treatment– 2022 & 2032
  • Figure 85 : Middle East & Africa Statins Market Y-o-Y Growth by Therapeutic Treatment, 2021– 2032
  • Figure 86 : Middle East & Africa Statins Market Attractiveness Analysis by Therapeutic Treatment, 2022– 2032
  • Figure 87 : Middle East & Africa Statins Market BPS Analysis by End User– 2022 & 2032
  • Figure 88 : Middle East & Africa Statins Market Y-o-Y Growth by End User, 2021– 2032
  • Figure 89 : Middle East & Africa Statins Market Attractiveness Analysis by End User, 2022– 2032

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organization of all sizes.

Persistence Market Research
Price: $4900

Become a Member

Already a member? Login here.

Have a Question? Ask Us.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
Custom Research

Need a custom data table, graph or complete report? Tell us more.

RELATED REPORTS